Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial
Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/formatting rather than substantive content changes.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a new frontend build without changes to the study information or navigation.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page adds new sections and metadata fields, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, and a Revision: v3.6.0 tag. It removes older labels such as Verified, Last known status was:, Intervention / Treatment, and Revision: v3.5.5.SummaryDifference2%

- Check39 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new version of the page content. This change does not alter the substantive study details.SummaryDifference0.1%

- Check61 days agoChange DetectedThe study record's revision history now shows a new revision label v3.5.4, replacing the previous v3.5.3, indicating an updated version of the page.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page footer site revision/version was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.